Long-Term Disease Control by Pomalidomide-/Dexamethasone-Based Therapy in a Patient with Advanced Multiple Myeloma: A Case Report and Review of the Literature

BACKGROUND: Therapy for multiple myeloma (MM) has substantially improved in the era of immunomodulatory drugs and bortezomib. However, the prognosis of patients with progressive disease despite treatment with these ‘novel agents’ remains poor. Recently, pomalidomide was approved in this setting, but...

Descripción completa

Detalles Bibliográficos
Autores principales: Danhof, Sophia, Schreder, Martin, Strifler, Susanne, Einsele, Hermann, Knop, Stefan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: S. Karger AG 2015
Materias:
Published online: April, 2015
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4427147/
https://www.ncbi.nlm.nih.gov/pubmed/25969681
http://dx.doi.org/10.1159/000381983

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4427147/
https://www.ncbi.nlm.nih.gov/pubmed/25969681
http://dx.doi.org/10.1159/000381983

Ejemplares similares